Comprehensive Stock Comparison

Compare Concord Medical Services Holdings Limited (CCM) vs Tenet Healthcare Corporation (THC) Stock

Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Try these comparisons:

Quick Verdict

CategoryWinnerWhy
GrowthTHC3.1% revenue growth vs CCM's -28.6%
ValueCCMLower P/E (0.9x vs 14.1x)
Quality / MarginsTHC6.6% net margin vs CCM's -44.6%
Stability / SafetyCCMBeta 0.25 vs THC's 0.93
DividendsTieNeither pays a meaningful dividend
Momentum (1Y)THC+89.1% vs CCM's -29.9%
Efficiency (ROA)THC4.7% ROA vs CCM's -2.4%, ROIC 13.5% vs -7.7%
Bottom line: THC leads in 4 of 7 categories, making it the stronger pick for investors who prioritize growth and revenue expansion and profitability and margin quality. Concord Medical Services Holdings Limited is the better choice for valuation and capital efficiency and capital preservation and lower volatility. As direct sector peers, they can serve as alternatives in the same portfolio allocation.

Who Each Stock Is For

Income & stability

Growth exposure

Long-term compounding (10Y)

Sleep-well-at-night portfolio

Defensive / Recession hedge

Business Model

What each company does and how it makes money

CCMConcord Medical Services Holdings Limited
Healthcare

Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers across China, specializing in cancer treatment services. It generates revenue primarily from operating its network of treatment centers — including linear accelerators and gamma knife systems — and from hospital management services, with additional income from equipment leasing and medical IT services. The company's competitive advantage lies in its established network of specialized cancer treatment facilities across China and its expertise in advanced radiotherapy technologies.

THCTenet Healthcare Corporation
Healthcare

Tenet Healthcare is a diversified healthcare services company that operates hospitals, ambulatory surgery centers, and urgent care facilities. It generates revenue primarily from hospital operations (acute care services) and ambulatory care centers, with additional income from its Conifer segment providing revenue cycle management services to other healthcare providers. The company's scale and integrated network of facilities across multiple states create operational efficiencies and referral pathways that serve as its competitive advantage.

Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
THCTenet Healthcare Corporation
FY 2024
Hospital Operations
55.5%$5.6B
Ambulatory Care
44.5%$4.5B

Financial Metrics Comparison

Side-by-side fundamentals across 2 stocks. BestLagging

Financial Scorecard

THC 3CCM 1
Financial MetricsTHC5/6 metrics
Valuation MetricsCCM3/4 metrics
Profitability & EfficiencyTHC7/9 metrics
Total ReturnsTHC6/6 metrics
Risk & VolatilityTie1/2 metrics
Analyst Outlook0/0 metrics

THC leads in 3 of 6 categories (Financial Metrics, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.

Financial Metrics (TTM)

THC is the larger business by revenue, generating $21.3B annually — 58.3x CCM's $366M. THC is the more profitable business, keeping 6.6% of every revenue dollar as net income compared to CCM's -44.6%. On growth, THC holds the edge at +9.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCMConcord Medical S…THCTenet Healthcare …
RevenueTrailing 12 months$366M$21.3B
EBITDAEarnings before interest/tax-$359M$4.4B
Net IncomeAfter-tax profit-$163M$1.4B
Free Cash FlowCash after capex$0$2.5B
Gross MarginGross profit ÷ Revenue-11.4%+55.9%
Operating MarginEBIT ÷ Revenue-131.0%+16.5%
Net MarginNet income ÷ Revenue-44.6%+6.6%
FCF MarginFCF ÷ Revenue-2.1%+11.9%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+9.0%
EPS Growth (YoY)Latest quarter vs prior year+84.0%+27.1%
THC leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

MetricCCMConcord Medical S…THCTenet Healthcare …
Market CapShares × price$167M$21.0B
Enterprise ValueMkt cap + debt − cash$708M$31.3B
Trailing P/EPrice ÷ TTM EPS-0.01x15.45x
Forward P/EPrice ÷ next-FY EPS est.0.87x14.12x
PEG RatioP/E ÷ EPS growth rate0.47x
EV / EBITDAEnterprise value multiple7.17x
Price / SalesMarket cap ÷ Revenue2.98x0.99x
Price / BookPrice ÷ Book value/share0.00x2.42x
Price / FCFMarket cap ÷ FCF8.32x
CCM leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

THC delivers a 15.7% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-9 for CCM. THC carries lower financial leverage with a 1.47x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), THC scores 7/9 vs CCM's 3/9, reflecting strong financial health.

MetricCCMConcord Medical S…THCTenet Healthcare …
ROE (TTM)Return on equity-9.5%+15.7%
ROA (TTM)Return on assets-2.4%+4.7%
ROICReturn on invested capital-7.7%+13.5%
ROCEReturn on capital employed-12.2%+14.1%
Piotroski ScoreFundamental quality 0–937
Debt / EquityFinancial leverage2.43x1.47x
Net DebtTotal debt minus cash$3.7B$10.3B
Cash & Equiv.Liquid assets$216M$2.9B
Total DebtShort + long-term debt$3.9B$13.2B
Interest CoverageEBIT ÷ Interest expense-2.40x5.85x
THC leads this category, winning 7 of 9 comparable metrics.

Total Returns (with DRIP)

A $10,000 investment in THC five years ago would be worth $45,270 today (with dividends reinvested), compared to $992 for CCM. Over the past 12 months, THC leads with a +89.1% total return vs CCM's -29.9%. The 3-year compound annual growth rate (CAGR) favors THC at 59.9% vs CCM's -36.5% — a key indicator of consistent wealth creation.

MetricCCMConcord Medical S…THCTenet Healthcare …
YTD ReturnYear-to-date-14.8%+20.0%
1-Year ReturnPast 12 months-29.9%+89.1%
3-Year ReturnCumulative with dividends-74.4%+309.0%
5-Year ReturnCumulative with dividends-90.1%+352.7%
10-Year ReturnCumulative with dividends-92.1%+864.5%
CAGR (3Y)Annualised 3-year return-36.5%+59.9%
THC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

CCM is the less volatile stock with a 0.25 beta — it tends to amplify market swings less than THC's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. THC currently trades 99.5% from its 52-week high vs CCM's 33.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCMConcord Medical S…THCTenet Healthcare …
Beta (5Y)Sensitivity to S&P 5000.25x0.93x
52-Week HighHighest price in past year$10.77$240.57
52-Week LowLowest price in past year$3.18$109.82
% of 52W HighCurrent price vs 52-week peak+33.8%+99.5%
RSI (14)Momentum oscillator 0–10041.974.5
Avg Volume (50D)Average daily shares traded7K826K
Evenly matched — CCM and THC each lead in 1 of 2 comparable metrics.

Analyst Outlook

Wall Street rates CCM as "Buy" and THC as "Buy".

MetricCCMConcord Medical S…THCTenet Healthcare …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$257.45
# AnalystsCovering analysts232
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+6.8%
Insufficient data to determine a leader in this category.

Historical Charts

Charts are rendered on first load. Hover for details.

Chart 1Total Return — 5 Years (Rebased to 100)

StockMar 20Feb 26Change
Concord Medical Ser… (CCM)10016.67-83.3%
Tenet Healthcare Co… (THC)100662.08+562.1%

Tenet Healthcare Co… (THC) returned +353% over 5 years vs Concord Medical Ser… (CCM)'s -90%. A $10,000 investment in THC 5 years ago would be worth $45,270 today (including dividends reinvested).

Chart 2Revenue Growth — 10 Years

Stock20162025Change
Concord Medical Ser… (CCM)$455M$384M-15.6%
Tenet Healthcare Co… (THC)$19.6B$21.3B+8.6%

Tenet Healthcare Corporation's revenue grew from $19.6B (2016) to $21.3B (2025) — a 0.9% CAGR.

Chart 3Net Margin Trend — 10 Years

Stock20162025Change
Concord Medical Ser… (CCM)-57.5%-80.3%-39.5%
Tenet Healthcare Co… (THC)-1.0%6.6%+774.8%

Tenet Healthcare Corporation's net margin went from -1% (2016) to 7% (2025).

Chart 4P/E Ratio History — 7 Years

Stock20182025Change
Tenet Healthcare Co… (THC)1612.8-20.0%

Tenet Healthcare Corporation has traded in a 4x–16x P/E range over 7 years; current trailing P/E is ~15x.

Chart 5EPS Growth — 10 Years

Stock20162025Change
Concord Medical Ser… (CCM)-1,804.2-2,116.8-17.3%
Tenet Healthcare Co… (THC)-1.9315.49+902.6%

Tenet Healthcare Corporation's EPS grew from $-1.93 (2016) to $15.49 (2025).

Chart 6Free Cash Flow — 5 Years

2021
$-1B
$910M
2022
$-600M
$321M
2023
$-392M
$2B
2024
$-809M
$1B
2025
$3B
Concord Medical Ser… (CCM)Tenet Healthcare Co… (THC)

Concord Medical Services Holdings Limited generated $-809M FCF in 2024 (+28% vs 2021). Tenet Healthcare Corporation generated $3B FCF in 2025 (+178% vs 2021).

Loading custom metrics...

CCM vs THC: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is CCM or THC a better buy right now?

Tenet Healthcare Corporation (THC) offers the better valuation at 15.5x trailing P/E (14.1x forward), making it the more compelling value choice. Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CCM or THC?

On forward P/E, Concord Medical Services Holdings Limited is actually cheaper at 0.9x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CCM or THC?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +352.7%, compared to -90.1% for Concord Medical Services Holdings Limited (CCM). A $10,000 investment in THC five years ago would be worth approximately $45K today (assuming dividends reinvested). Over 10 years, the gap is even starker: THC returned +864.5% versus CCM's -92.1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CCM or THC?

By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.25β versus Tenet Healthcare Corporation's 0.93β — meaning THC is approximately 271% more volatile than CCM relative to the S&P 500. On balance sheet safety, Tenet Healthcare Corporation (THC) carries a lower debt/equity ratio of 147% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

05

Which has better profit margins — CCM or THC?

Tenet Healthcare Corporation (THC) is the more profitable company, earning 6.6% net margin versus -80.3% for Concord Medical Services Holdings Limited — meaning it keeps 6.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16.5% versus -138.6% for CCM. At the gross margin level — before operating expenses — THC leads at 41.4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is CCM or THC more undervalued right now?

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 0.9x forward P/E versus 14.1x for Tenet Healthcare Corporation — 13.3x cheaper on a one-year earnings basis.

07

Which pays a better dividend — CCM or THC?

None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is CCM or THC better for a retirement portfolio?

For long-horizon retirement investors, Tenet Healthcare Corporation (THC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.93), +864.5% 10Y return). Both have compounded well over 10 years (THC: +864.5%, CCM: -92.1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between CCM and THC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: CCM is a small-cap quality compounder stock; THC is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.

📊
Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
📊
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Better Than Both

Find stocks that beat CCM and THC on the metrics you choose

Revenue Growth>
%
(CCM: -8.3% · THC: 9.0%)